Stan Rose

Stan Rose has over 35 years of experience in the life sciences industry, with a focus on early-stage companies and innovative products. Stan is currently the President of Rose Ventures Inc., which provides financing, advisory services, and a network of industry connections to support the growth of emerging companies. In addition, they serve as a Director for multiple companies, including Invenra, SerumDPT, and Xeno Biosciences.

Stan has held various leadership positions throughout their career, including CEO and Co-Founder of Eurofins Transplant Genomics, where they developed gene expression tests for kidney transplant recipients. Stan was also the Chief Executive Officer of Roche NimbleGen Inc. and served as COO and Co-Founder of Genetic MicroSystems.

Prior to these roles, Stan held positions at Perkin-Elmer / Applied Biosystems and Collaborative Research, where they were responsible for managing and directing DNA products and services. Stan brings a wealth of knowledge and expertise to the life sciences industry, making him a valuable asset in driving growth and innovation in the field.

Stan Rose received a Bachelor's degree in Psychology from Cornell University in an unspecified year. Following that, they pursued a Doctor of Philosophy (PhD) degree in Biology/Biological Sciences, General from the Massachusetts Institute of Technology, which they completed in 1985.